Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henri Lu

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
JACC. Heart Failure|August 26, 2025
Temporal Changes in Biomarkers, Functional Status, and Quality of Life Prior to Adverse Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection FractionHenri Lu, Brian L Claggett, Muthiah Vaduganathan, et al.
JACC. Heart Failure|June 24, 2026
Sleep Apnea in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF TrialHenri Lu, Sophia R Schneider, Maria A Pabón, et al.
European Heart Journal|May 11, 2026
Viral respiratory tract infections in heart failure: the FINEARTS-HF trialRagnhild Helseth, Brian L Claggett, Ankeet Bhatt, et al.
Diabetes Care|December 8, 2025
Interplay Between Heart Failure Events, New-Onset Diabetes, and Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection FractionJohn W Ostrominski, Henri Lu, Brian L Claggett, et al.
Journal of the American Heart Association|December 11, 2025
Study Protocol for HeartMagic: A Prospective Observational Cohort Characterizing Subtypes of Heart Failure With Preserved Ejection FractionPhilippe Meyer, Angela Rocca, Jaume Banus, et al.
Circulation. Heart Failure|August 30, 2024
Relationship Between Cardiac Structure and Function With Renal Function Trajectory and Outcomes in Patients With Heart Failure: Insights From the PARAGON-HF TrialHenri Lu, Safia Chatur, Sahmin Lee, et al.
Journal of the American Heart Association|April 23, 2025
Prognostic Significance of Nutritional Scores in Patients With Heart Failure: Insights From the PARAGON-HF TrialHenri Lu, Brian L Claggett, Masatoshi Minamisawa, et al.
JAMA Cardiology|March 28, 2026
Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical TrialHenri Lu, Annamaria Kosztin, Brian L Claggett, et al.
JACC. Heart Failure|March 6, 2025
Severe Heart Failure and Treatment With Dapagliflozin Across the Ejection Fraction Spectrum: DAPA-HF and DELIVERRiccardo M Inciardi, Henri Lu, Brian L Claggett, et al.
JACC. Heart Failure|April 25, 2024
Sex Differences in Heart Failure With Improved Ejection Fraction: The DELIVER TrialMaria A Pabón, Xiaowen Wang, Carolyn S P Lam, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
JACC. Heart Failure|August 26, 2025
Temporal Changes in Biomarkers, Functional Status, and Quality of Life Prior to Adverse Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection FractionHenri Lu, Brian L Claggett, Muthiah Vaduganathan, et al.
JACC. Heart Failure|June 24, 2026
Sleep Apnea in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF TrialHenri Lu, Sophia R Schneider, Maria A Pabón, et al.
European Heart Journal|May 11, 2026
Viral respiratory tract infections in heart failure: the FINEARTS-HF trialRagnhild Helseth, Brian L Claggett, Ankeet Bhatt, et al.
Diabetes Care|December 8, 2025
Interplay Between Heart Failure Events, New-Onset Diabetes, and Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection FractionJohn W Ostrominski, Henri Lu, Brian L Claggett, et al.
Journal of the American Heart Association|December 11, 2025
Study Protocol for HeartMagic: A Prospective Observational Cohort Characterizing Subtypes of Heart Failure With Preserved Ejection FractionPhilippe Meyer, Angela Rocca, Jaume Banus, et al.
Circulation. Heart Failure|August 30, 2024
Relationship Between Cardiac Structure and Function With Renal Function Trajectory and Outcomes in Patients With Heart Failure: Insights From the PARAGON-HF TrialHenri Lu, Safia Chatur, Sahmin Lee, et al.
Journal of the American Heart Association|April 23, 2025
Prognostic Significance of Nutritional Scores in Patients With Heart Failure: Insights From the PARAGON-HF TrialHenri Lu, Brian L Claggett, Masatoshi Minamisawa, et al.
JAMA Cardiology|March 28, 2026
Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical TrialHenri Lu, Annamaria Kosztin, Brian L Claggett, et al.
JACC. Heart Failure|March 6, 2025
Severe Heart Failure and Treatment With Dapagliflozin Across the Ejection Fraction Spectrum: DAPA-HF and DELIVERRiccardo M Inciardi, Henri Lu, Brian L Claggett, et al.
JACC. Heart Failure|April 25, 2024
Sex Differences in Heart Failure With Improved Ejection Fraction: The DELIVER TrialMaria A Pabón, Xiaowen Wang, Carolyn S P Lam, et al.
Pageof 10